EcoDrugPlus

Endothelin Converting Enzyme 1

Ensembl ID : ENSMSIG00000012640
Gene Symbol: ECE1
1 Cross references
245 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSMSIG00000009317
Gene Symbol: EDNRA
1 Cross references
279 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSMSIG00000014893
Gene Symbol: EDNRB
1 Cross references
279 Possible Orthologues:

Epidermal Growth Factor Receptor

Ensembl ID : ENSMSIG00000001122
Gene Symbol: EGFR
1 Cross references
300 Possible Orthologues:

Epoxide Hydrolase 2, Cytoplasmic

Ensembl ID : ENSMSIG00000018278
Gene Symbol: EPHX2
1 Cross references
218 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSMSIG00000016883
Gene Symbol: ERBB2
1 Cross references
215 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSMSIG00000000751
Gene Symbol: ERBB3
1 Cross references
297 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSMSIG00000003165
Gene Symbol: ERBB4
1 Cross references
251 Possible Orthologues:

Estrogen Receptor 1 (Alpha)

Ensembl ID : ENSMSIG00000029132
Gene Symbol: ESR1
1 Cross references
225 Possible Orthologues:

Estrogen Receptor 2 (Beta)

Ensembl ID : ENSMSIG00000010420
Gene Symbol: ESR2
1 Cross references
288 Possible Orthologues:

Estrogen-Related Receptor Gamma

Ensembl ID : ENSMSIG00000029593
Gene Symbol: ESRRG
1 Cross references
292 Possible Orthologues:

Exportin 1

Ensembl ID : ENSMSIG00000031855
Gene Symbol: XPO1
1 Cross references
319 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).